Fig. 3
From: DNA hypermethylation markers of poor outcome in laryngeal cancer
Patients with late stage disease (n = 40, stage 3 and 4) had poorer survival as compared to those with early stage disease (n = 38, stage 0, 1, and 2)
Fig. 3 | Clinical Epigenetics